RxDoctor Payments Data

Jesus Hidalgo, MD

Undersea and Hyperbaric Medicine · Lubbock, TXNPI 1255656476

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,675 of the $2,360 with a category attached, or 71.0%. 19 manufacturers reported payments, led by Medtronic at 30.0% of the total. Reporting peaked in 2019 at $1,294 and has fallen 95.8% since, to $55 in 2025.

$2,360in general payments, 2019–2025

Across 86 payments — averaging $27.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$708
  • Smith+Nephew$329
  • AbbVie$199
  • Organogenesis Inc.$199
  • Tactile Systems Technology Inc$172
  • Angiodynamics, Inc.$137
  • plus $616 from 13 others

What the payments were for

  • Travel & lodging$68229%
  • Food & beverage$1,67571%
  • Education$30%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,360 in reported general payments places this provider in the 65th percentile of 59 undersea and hyperbaric medicine providers in Texas.

See all undersea and hyperbaric medicine providers in Texas

Medicare billing

Part B allowed, 2024
$3,861,561
Medicare patients
310
Services billed
30,785

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate451$17,558
Metronidazole32$2,008
Clobetasol Propionate56$1,553
Doxycycline Hyclate94$1,283
Pentoxifylline17$1,243
Mupirocin139$1,158
Clindamycin Hcl51$975
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav36$438
Gabapentin31$365
Minocycline Hcl18$362
Nystatin11$176
Levofloxacin28$134
Potassium Chloride20$69
Furosemide23$55

Paid to pharmacies, not to this prescriber.

Other undersea and hyperbaric medicine in Lubbock

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →